MedTech Revenue Operations:
Why Your CRM Is Launch Infrastructure

Most MedTech companies buy a CRM the week their first sales rep starts, and configure it the way the rep used it at their last job. That is backward. MedTech revenue operations, the systems and processes that connect marketing, sales, and service data, should be designed before anyone carries a quota, because in this industry the commercial system also carries compliance obligations.

The cost of getting it wrong shows up in selling time. Across industries, sales reps report spending 70% of their time on non-selling tasks, and only 35% of sales professionals completely trust the accuracy of their organization's data.¹ A launch-stage device company, with a small team and a short runway, cannot afford either number.

MedTech adds two requirements a software company never faces. Payments to physicians have to be tracked for federal disclosure, and product complaints heard in the field have to reach your quality system. Both start in the same place your pipeline does: a rep's conversation with a clinician.

The following post breaks down what revenue operations means for a device company, where the compliance obligations sit, how to model a hospital sale in your CRM, and the minimum stack to have in place before your first rep starts.

What Revenue Operations Means for a MedTech Company

Revenue operations is the shared data, tooling, and process layer that marketing, sales, and customer support all run on. In a mature company it is a team. In a launch-stage MedTech company it is usually one part-time owner and a set of decisions that either get made on purpose or get made by default.

The decisions are concrete: which accounts you target and how they roll up to health systems, which fields are required before a deal can advance, who owns a lead after a conference, and how a field conversation becomes a record that finance, quality, and leadership can all use.

For a device company, MedTech commercial operations also has to reflect a buyer that is a committee rather than a person. A surgeon champions the product, a value analysis committee reviews it, supply chain negotiates it, and finance approves it. Your system has to track all four.

Why a Medical Device CRM Has Compliance Built In

A medical device CRM is a regulated record in practice, even when nobody treats it that way. Two federal requirements run directly through the interactions your team logs.

Open Payments Starts With a Logged Interaction

The federal Open Payments program, created by the Sunshine Act, requires drug and device manufacturers that fall under the program to report payments and other transfers of value to physicians, non-physician practitioners, and teaching hospitals. For program year 2024, CMS published 16.16 million records totaling $13.18 billion.²

The thresholds are low. For 2026, a single transfer of value over $13.82 is reportable, as are smaller ones that add up to more than $138.13 for one recipient across the year.³ A catered lunch for a surgical team or a sponsored conference dinner can cross that line. If those interactions are not captured with the recipient's identity at the time they happen, someone reconstructs them from expense reports the following spring.

Complaints Heard in the Field Belong in Your Quality System

FDA's Quality Management System Regulation, which took effect February 2, 2026, incorporates the ISO 13485:2016 standard into device manufacturing requirements.⁴ It requires manufacturers to keep complaint records that include the device name, the date the complaint was received, device identifiers, complainant contact information, and the nature and details of the complaint.⁵

Your reps hear complaints first. A surgeon mentions a failure during a case, and it lands in a call note. If your CRM has no defined path from that note to your quality team, the date-received field is already a problem by the time anyone notices.

Build Deal Stages Around How Hospitals Actually Buy

Most CRMs ship with default stages built for software sales: qualified, demo, proposal, negotiation, closed. A hospital does not buy a device that way, and a pipeline built on those stages will forecast badly.

A hospital sale has gates your company does not control. The product needs a clinical champion, then a value analysis committee submission on that committee's meeting calendar, then often a trial or evaluation period, then a contract through supply chain or a group purchasing organization. Each gate has its own owner and its own timeline. We covered how those committees decide in our post on value analysis committee strategy.

The stages we recommend reflect those gates:

1. Champion identified. A named clinician has seen the product and wants it.
2. VAC submitted. The dossier is filed, with the committee's next meeting date recorded.
3. Approved for evaluation. The committee has cleared a trial with defined success criteria.
4. Evaluation complete. Cases are done and outcome data is collected.
5. Contracting. Pricing and terms are with supply chain or a GPO.
6. First order. A purchase order is in hand. A verbal commitment does not count.

A forecast built on these stages tells you which deals are waiting on a committee date and which are waiting on your team. That distinction is the whole value of a pipeline.

The Minimum Viable Revenue Stack Before Your First Rep Starts

A launch-stage company does not need an enterprise tech stack. It needs a short list of things decided and configured before the first rep's first day, so that the first 90 days of field data are usable rather than cleaned up later. Cicada, a MedTech launch partner, works through this list with clients as part of building operational infrastructure:

• An account hierarchy. Hospitals mapped to their parent health systems and GPO affiliations, with value analysis committee meeting cadence recorded where you can find it.
• Clean contact records. Clinicians stored with the identifiers Open Payments reporting needs, so transfers of value attach to the right person.
• An interaction log with a transfer-of-value field. Every meal, sample, or sponsorship captured when it happens.
• A complaint path. A required field or button in the call note that routes possible complaints to quality, written with your quality lead.
• Hospital-shaped deal stages. The six gates above, with required fields at each one.
• One source of lead truth. Conference scans, website inquiries, and webinar registrations flowing into the same system the sales team works from.

None of this requires an expensive platform. It requires decisions, which are far cheaper to make before there are thousands of records to migrate.

Where Medical Device Sales Operations Usually Break

These failure patterns repeat across launches, and each one is cheaper to prevent than to fix.

The spreadsheet that became the system. Early accounts get tracked in a shared sheet, and by the time the company adopts a CRM, the sheet has three versions and no history. Migration costs weeks and loses context.

The CRM configured by the first hire. A new sales leader sets up the system the way their last employer did. If that employer was a large strategic manufacturer with a separate compliance stack, none of the Open Payments or complaint logic comes with it.

Marketing and sales on separate islands. Marketing generates conference leads in one tool, sales works deals in another, and nobody can say which channel produced a closed account. That makes the next budget decision a guess.

Distributor blackout. Companies that launch through distributors often lose visibility into accounts and interactions entirely. If you use distributors, write data-sharing requirements into the agreement before signing.

Frequently Asked Questions About MedTech Revenue Operations

MedTech Revenue Operations Is Part of the Launch

MedTech revenue operations is easy to treat as administrative work that can wait until there is revenue to operate. In this industry it cannot, because the same system that tracks your pipeline is where transfers of value and field complaints first appear.

Companies that design the system before the first rep starts get a usable forecast, cleaner compliance, and a clear line from marketing spend to closed accounts. Companies that wait spend their second year cleaning up the first. If you want help building that foundation, see how we do it, or read how it fits into the broader post-clearance commercialization timeline.

Related reading: Medical Device Marketing Strategy: Why Trust Is an Infrastructure Problem